Covered recipient · General Payments record
ROBERT F GAGEL
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2019
$54,471.41
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $21,669.52 | 3 |
| Consulting Fee | $19,650.00 | 5 |
| Food and Beverage | $200.30 | 4 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $37,774.06 | 8 |
| Novo Nordisk AS | $3,600.00 | 1 |
| Amgen Inc. | $145.76 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $23.53 | 11/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | 663344117 | CMS |
| Amgen Inc. | $75.63 | 11/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | 663344121 | CMS |
| Amgen Inc. | $46.60 | 11/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | 663344125 | CMS |
| Novo Nordisk AS | $3,600.00 | 05/16/2019 | Consulting Fee | Undisputed | 01/23/2026 | 706588909 | CMS |
| Novo Nordisk Inc | $9,875.00 | 02/26/2019 | Travel and Lodging | Undisputed | 01/23/2026 | 706658885 | CMS |
| Novo Nordisk Inc | $3,600.00 | 02/26/2019 | Consulting Fee | Undisputed | 01/23/2026 | 706659927 | CMS |
| Novo Nordisk Inc | $1,200.00 | 02/26/2019 | Consulting Fee | Undisputed | 01/23/2026 | 706660167 | CMS |
| Novo Nordisk Inc | $54.54 | 09/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | 705942863 | CMS |
| Novo Nordisk Inc | $11,360.89 | 09/19/2019 | Travel and Lodging | Undisputed | 01/23/2026 | 706572813 | CMS |
| Novo Nordisk Inc | $433.63 | 09/19/2019 | Travel and Lodging | Undisputed | 01/23/2026 | 706572815 | CMS |
| Novo Nordisk Inc | $9,450.00 | 09/19/2019 | Consulting Fee | Undisputed | 01/23/2026 | 706575049 | CMS |
| Novo Nordisk Inc | $1,800.00 | 11/21/2019 | Consulting Fee | Undisputed | 01/23/2026 | 706575093 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.